These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3878855)

  • 1. Therapy of peritoneal murine cancer with biological response modifiers.
    Salup RR; Herberman RB; Chirigos MA; Back T; Wiltrout RH
    J Immunopharmacol; 1985; 7(4):417-36. PubMed ID: 3878855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.
    Salup RR; Wiltrout RH
    Cancer Immunol Immunother; 1986; 22(1):31-6. PubMed ID: 3486715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes.
    Salup RR; Wiltrout RH
    Cancer Res; 1986 Jul; 46(7):3358-63. PubMed ID: 3486710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
    J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
    J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural killer activity in development of spontaneous metastases in murine renal cancer.
    Salup RR; Herberman RB; Wiltrout RH
    J Urol; 1985 Dec; 134(6):1236-41. PubMed ID: 4057425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced incidence of rat colon cancer metastases by perioperative immunostimulation with maleic anhydride-divinyl ether-2 (MVE-2).
    Weese JL; Gilbertson EM; Syrjala SE; Whitney PD; Starling JR
    Dis Colon Rectum; 1985 Apr; 28(4):217-21. PubMed ID: 3979221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of the Madison 109 lung carcinoma to maleic vinyl ether copolymer.
    Klykken PC; Loveless SE; Morahan PS; Munson AE
    J Immunopharmacol; 1983; 5(1-2):31-47. PubMed ID: 6655250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of biological response modifiers on a spontaneous murine renal cell carcinoma regression of metastases caused by the streptococcal preparation OK-432].
    Tanji S
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):716-25. PubMed ID: 1875566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of nonspecific immunotherapy of experimental lung metastases by indomethacin.
    Schultz RM; Altom MG
    J Immunopharmacol; 1983; 5(4):277-90. PubMed ID: 6421937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of macrophages in the immunotherapy of Lewis lung peritoneal carcinomatosis.
    Wallace PK; Morahan PS
    J Leukoc Biol; 1994 Jul; 56(1):41-51. PubMed ID: 8027669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma.
    Younes E; Haas GP; Dezso B; Ali E; Maughan RL; Kukuruga MA; Montecillo E; Pontes JE; Hillman GG
    Cell Immunol; 1995 Oct; 165(2):243-51. PubMed ID: 7553889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tumor site on the therapy of murine kidney cancer.
    Chakrabarty A; Hillman GG; Maughan RL; Visscher DW; Ali E; Pontes JE; Haas GP
    Anticancer Res; 1994; 14(2A):373-8. PubMed ID: 8017836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of advanced murine renal cell cancer by bicompartmental adoptive chemoimmunotherapy.
    Salup RR; Back TC; Wiltrout RH
    J Immunol; 1987 Jan; 138(2):641-7. PubMed ID: 3491854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
    Chirigos MA; Schlick E; Saito T; Gruys E
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):27-33. PubMed ID: 3486334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.
    Wiltrout RH; Boyd MR; Back TC; Salup RR; Arthur JA; Hornung RL
    J Immunol; 1988 May; 140(9):3261-5. PubMed ID: 3258894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.